Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Hsu Wang

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Diagnostics (Basel, Switzerland)|March 6, 2021
Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck CancerKun-Yun Yeh, Hang Huong Ling, Shu-Hang Ng, et al.
Nutrients|September 28, 2021
Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity CancerYu-Ching Lin, Hang Huong Ling, Pei-Hung Chang, et al.
Journal of Pain and Symptom Management|April 29, 2017
Terminally Ill Taiwanese Cancer Patients' and Family Caregivers' Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional StudiesTsang-Wu Liu, Fur-Hsing Wen, Cheng-Hsu Wang, et al.
Annals of Surgical Oncology|July 20, 2007
Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinomaHwei-Ming Wang, Yu-Wen Huang, Jen-Seng Huang, et al.
Biomedicines|February 25, 2022
Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent ChemoradiotherapyYu-Ching Lin, Cheng-Hsu Wang, Hang Huong Ling, et al.
Anti-Cancer Drugs|October 8, 2010
Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expressionYing-Ying Li, John W-C Chang, Ying-Chieh Liu, et al.
Melanoma Research|December 4, 2004
Malignant melanoma in Taiwan: a prognostic study of 181 casesJohn Wen-Cheng Chang, Kun-Yun Yeh, Cheng-Hsu Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2007
Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancersYing-Ying Li, John W-C Chang, Wen-Chi Chou, et al.
Head & Neck|July 9, 2017
Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapyPei-Hung Chang, Kun-Yun Yeh, Cheng-Hsu Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 22, 2017
Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancerPei-Hung Chang, Cheng-Hsu Wang, Eric Yen-Chao Chen, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Diagnostics (Basel, Switzerland)|March 6, 2021
Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck CancerKun-Yun Yeh, Hang Huong Ling, Shu-Hang Ng, et al.
Nutrients|September 28, 2021
Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity CancerYu-Ching Lin, Hang Huong Ling, Pei-Hung Chang, et al.
Journal of Pain and Symptom Management|April 29, 2017
Terminally Ill Taiwanese Cancer Patients' and Family Caregivers' Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional StudiesTsang-Wu Liu, Fur-Hsing Wen, Cheng-Hsu Wang, et al.
Annals of Surgical Oncology|July 20, 2007
Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinomaHwei-Ming Wang, Yu-Wen Huang, Jen-Seng Huang, et al.
Biomedicines|February 25, 2022
Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent ChemoradiotherapyYu-Ching Lin, Cheng-Hsu Wang, Hang Huong Ling, et al.
Anti-Cancer Drugs|October 8, 2010
Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expressionYing-Ying Li, John W-C Chang, Ying-Chieh Liu, et al.
Melanoma Research|December 4, 2004
Malignant melanoma in Taiwan: a prognostic study of 181 casesJohn Wen-Cheng Chang, Kun-Yun Yeh, Cheng-Hsu Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2007
Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancersYing-Ying Li, John W-C Chang, Wen-Chi Chou, et al.
Head & Neck|July 9, 2017
Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapyPei-Hung Chang, Kun-Yun Yeh, Cheng-Hsu Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 22, 2017
Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancerPei-Hung Chang, Cheng-Hsu Wang, Eric Yen-Chao Chen, et al.
Pageof 8